The chromosomal region containing ID4 (6p22) is amplified in 32% of high-grade serous ovarian cancers (HG-SOC) [15], and ID4 is over-expressed in most primary ovarian cancers and ovarian cancer cell lines, but not in normal ovaries [16]. This evidence concerns the gene ID4 and ovarian cancer.